| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Surgery, VU University medical center, Amsterdam, Netherlands
2 Surgery, University of Maastricht, Maastricht, United States
3 Surgery, University of Maastricht, Maastricht, Netherlands
* To whom correspondence should be addressed. E-mail: pam.vleeuwen{at}vumc.nl.
A pathway from enteral L-glutamine as substrate for L-arginine synthesis is suggested from previous studies. L-glutamine and L-glutamine dipeptides exhibit numerous beneficial effects in experimental and clinical studies. In trauma patients, enteral L-glutamine supply increased plasma L-arginine. The present study was designed to quantify the contribution of L-glutamine to the de novo L-citrulline and L-arginine synthesis in mice, when L-glutamine is administered in a high dose of labelled L-glutamine or L-alanyl-L-glutamine by the enteral or parenteral route. For this purpose, male Swiss mice (n=43) underwent a laparotomy and catheters were inserted for sampling and infusion. A primed, constant and continuous infusion of L-alanyl-L-[2,15N]glutamine (dipeptide groups) or L-[2,15N]glutamine (free L-glutamine groups), simultaneously with L-[ureido-13C-2H2]citrulline and L-[guanidino-15N2-2H2]arginine, was given (steady state model). Mice received the L-glutamine-tracers intravenously (jugular vein) or enterally (duodenum). Enrichments of metabolites were measured by liquid chromatography-mass spectrometry. Arterial L-glutamine concentrations were the highest in the intravenous dipeptide group. L glutamine was converted to L-citrulline and L-arginine when L-[2,15N]glutamine and L-alanyl-L-[2,15N]glutamine were given by enteral or parenteral route. The contribution of L-glutamine to the de novo synthesis of L-citrulline and L-arginine was higher in the enteral groups when compared with the intravenous groups (p<0.005). Therefore, the route of administration (enteral or parenteral) affects the contribution of L-glutamine, provided as free molecule or dipeptide, to the de novo synthesis of L-arginine in mice.
This article has been cited by other articles:
|
|
 |
|
  G. C Ligthart-Melis, M. C. van de Poll, M. A. Vermeulen, P. G Boelens, M P. van den Tol, C. van Schaik, J.-P. De Bandt, N. E. Deutz, C. H. Dejong, and P. A. van Leeuwen Enteral administration of alanyl-[2-15N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans Am. J. Clinical Nutrition, July 1, 2009; 90(1): 95 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C Ligthart-Melis, M. C. van de Poll, P. G Boelens, C. H. Dejong, N. E. Deutz, and P. A. van Leeuwen Glutamine is an important precursor for de novo synthesis of arginine in humans Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xue, M. B. Sawyer, C. J. Field, L. A. Dieleman, D. Murray, and V. E. Baracos Bolus Oral Glutamine Protects Rats against CPT-11-Induced Diarrhea and Differentially Activates Cytoprotective Mechanisms in Host Intestine but Not Tumor J. Nutr., April 1, 2008; 138(4): 740 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Marini, A. Erez, L. Castillo, and B. Lee Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1764 - E1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Ligthart-Melis, M. C. G. van de Poll, C. H. C. Dejong, P. G. Boelens, N. E. P. Deutz, and P. A. M. van Leeuwen The Route of Administration (Enteral or Parenteral) Affects the Conversion of Isotopically Labeled L-[2-15N]Glutamine Into Citrulline and Arginine in Humans JPEN J Parenter Enteral Nutr, September 1, 2007; 31(5): 343 - 350. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
